Clinical practice guidelines for attention-deficit/ hyperactivity disorder: A review

Postgraduate Medicine

Volumn 122, Issue 5, 2010, Pages 69-77

  Bukstein, Oscar G ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

ADHD; Clinical practice guidelines; Stimulants; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; CLONIDINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; PEMOLINE; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; COMORBIDITY; CONFLICT; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; LIFESPAN; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PATIENT CARE PLANNING; PATIENT MONITORING; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE; REVIEW; DELAYED RELEASE FORMULATION; PSYCHOTHERAPY;

ADRENERGIC ALPHA-AGONISTS; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DELAYED-ACTION PREPARATIONS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY;

EID: 78049525929     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.09.2203     Document Type: Review

References (21)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 2000.
2. Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001;285(1):60-66.
3. Surgeon General of the United States. Mental Health: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 1999. http://mentalhealth.samhsa.gov/features/surgeongeneralreport/home.asp. Accessed August 9, 2010.
4. Centers for Disease Control and Prevention (CDC). Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. MMWR Morb Mortal Wkly Report. 2005;54(34):842-847.
5. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857-864.
6. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):724-732.
7. Institute of Medicine. Clinical Practice Guidelines: Directions for a New Program. Field MJ, Lohr KN, eds. Committee to Advise the Public Health Service on Clinical Practice Guidelines, Institute of Medicine. Washington, DC: National Academy Press; 1990.
8. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12(1):18-23.
9. American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033-1044.
10. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics. 2000;105(5):1158-1170.
11. Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921.
12. National Institute for Health and Clinical Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People, and Adults. London, UK: National Collaborating Centre for Mental Health; 2008. http://www.nice.org.uk/nicemedia/pdf/ADHDFullGuideline.pdf. Accessed August 9, 2010.
13. Scottish Intercollegiate Guidelines Network. Management of attention deficit and hyperkinetic disorders in children and young people. A National Clinical Guideline NHS Quality Improvement Scotland (NHS QIS) 2009. http://www.sign.ac.uk/pdf/sign112.pdf. Accessed August 9, 2010.
14. The Royal Austalasian College of Physicians. Australian Guidelines on Attention Deficit Hyperactivity Disorder (ADHD). 2009. http://www.nhmrc.gov.au/publications/synopses/adhd_draft.htm. Accessed August 5, 2010.
15. Nutt DJ, Fone K, Asherson P, et al; Association for Psychopharmacology. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007;21(1):10-41.
16. Taylor E, Döpfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry. 2004;13(suppl 1):17-30.
17. Pliska SR, Crismon ML, Hughes CW, et al; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642-657.
18. Pliszka SR, Lopez M, Crismon ML. A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry. 2003;42(3):279-287.
19. Magellan Health Services, Clinical Practice Guideline Task Force, Clinical Practice Guideline for Patients with Attention Deficit/Hyperactivity Disorder, 2005-2010. Magellan Health Services, Inc. http://www.westernhealth.com/providers/downloads/Clinical_Practice_Guidline_ADHD.pdf. Accessed August 9, 2010.
20. American Academy of Child and Adolescent Psychiatry (Pliszka SR, Bukstein OG). Attention Deficit/Hyperactivity Disorder, Version 3.0. Baltimore, MD: International Guidelines Center.
21. Davis K, Schoenbaum SC, Audet AM. A 2020 vision of patient-centered primary care. J Gen Intern Med. 2005;20(10):953-957.